Soaring healthcare costs show little sign of slowing in 2024, with concerns growing about the affordability of medications and medical services.
Ellen Kelsay
Advertisement
Articles by Ellen Kelsay
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Stock Reacts to Recent Board Changes
2
MJH Life Sciences Acquires BPD Healthcare, Expands Reach Among Health Systems and Innovators
3
Bob Mauch: Strengthening the Chain
4
Takeda and Innovent Biologics Announce Strategic Global Partnership
5
